A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): final week 96 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Ramji, Alnoor ^{[3
]}

Fung, Scott ^{[4
]}

Ahn, Sang Hoon ^{[5
]}

Chuang, Wan-Long ^{[6
]}

Yoon, Seung Kew ^{[7
]}

Kao, Jia-Horng ^{[8
]}

Chen, Chi-Yi ^{[9
]}

Tam, Edward ^{[10
]}

Khalili, Mandana ^{[11
]}

Bae, Ho ^{[12
]}

Ma, Xiaoli ^{[13
]}

Tak, Won Young ^{[14
]}

Flaherty, John F. ^{[15
]}

Gaggar, Anuj ^{[15
]}

Suri, Vithika ^{[15
]}

Tan, Susanna ^{[15
]}

Liu, Yang ^{[15
]}

Wu, George ^{[15
]}

Subramanian, Mani ^{[15
]}

Hann, Hie-Won ^{[16
]}

Agarwal, Kosh ^{[17
]}

Lim, Young-Suk ^{[18
,19
]}

Chan, Henry ^{[19
,20
]}

机构：

[1] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy

[2] Hosp Gen Univ Valle Hebron & Ciberehd, Barcelona, Spain

[3] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada

[4] Toronto Gen Hosp, Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada

[5] Yonsei Univ, Inst Gastroenterol, Dept Internal Med, Coll Med, Seoul, South Korea

[6] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea

[8] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan

[9] Chia Yi Christian Hosp, Chiayi, Taiwan

[10] LAIR Ctr, Vancouver, BC, Canada

[11] Univ Calif San Francisco, San Francisco, CA 94143 USA

[12] St Vincents Med Ctr, Los Angeles, CA USA

[13] Drexel Univ, Coll Med, Philadelphia, PA USA

[14] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[15] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[16] Thomas Jefferson Univ Hosp, Div Gastroenterol & Hepatol, Philadelphia, PA USA

[17] Kings Coll Hosp London, Inst Liver Studies, London, England

[18] Univ Ulsan, Ctr Liver, Asan Med Ctr, Dept Gastroenterol,Coll Med, Ulsan, South Korea

[19] Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China

[20] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AS091

引用

页码：S67 / S68

页数：2

共 50 条

[31] Week 96 Efficacy and Safety of Tenofovir Alafenamide (TAF) versus Tenofovir Disoproxil Fumarate (TDF) in Older, HIV-Infected Treatment-Naive Adults
Ward, D.
Thompson, M.
Goldstein, D.
Brinson, C.
Crofoot, G.
Kinder, C.
Ryu, J.
McNicholl, I.
Haubrich, R.
Weinberg, A.
Sparrow, T. L.
McCallister, S.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S48 - S48
[32] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE (TAF) VS TENOFOVIR DISOPROXIL FUMARATE (TDF) IN EAST ASIAN CHRONIC HEPATITIS B PATIENTS FOLLOWING 5-YEARS OF TREATMENT
Wong, Grace Lai Hung
Gane, Edward
Pan, Calvin
Lim, Young-Suk
Fung, Scott
Izumi, Namiki
Ma, Mang
Chan, Carol Yee Kwan
Shalimar, Dr
Buti, Maria
GUT, 2021, 70 : A76 - A76
[33] Switching from a tenofovir disoproxil fumarate (TDF)-based regimen to a tenofovir alafenamide (TAF)-based regimen: data in virologically suppressed adults through 48 weeks of treatment
Mills, Tony
Andrade, Jamie
Diperri, Giovanni
Van Lunzen, Jan
Koenig, Ellen
Elion, Richard
Cavassini, Matthias
Madruga, Jose Valdez
Brunetta, Jason
Shamblaw, David
Dejesus, Edwin
Cohen, Calvin
Plummer, Andrew
Liu, Yapei
McCallister, Scott
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
[34] BONE AND RENAL SAFETY ARE IMPROVED IN CHRONIC HBV PATIENTS 1 YEAR AFTER SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) FROM TENOFOVIR DISOPROXIL FUMARATE (TDF)
Chan, Henry Lik Yuen
Seto, Wai Kay
Buti, Maria
Izumi, Namiki
Lim, Young-Suk
Kao, Jia-Horng
Streinu-Cercel, Adrian
Nurmukhametova, Elena
Ma, Xiaoli
Tabak, Fehmi
Jablkowski, Maciej
Suri, Vithika
Flaherty, John
Lau, Audrey
Gaggar, Anuj
Mo, Shuyuan
Chowdhury, Abhijit
Fung, Scott
Chuang, Wan-Long
Gane, Edward
GUT, 2019, 68 : A141 - A142
[35] EFFECTIVENESS AND SAFETY OF SWITCHING TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR TO TENOFOVIR ALAFENAMIDE FUMARATE ( TAF) IN VIROLOGICALLY SUPPRESSED CHRONIC HEPATITIS B VIRUSINFECTED PATIENTS WITH ONEMINUTE OSTEOPOROSIS RISK TEST
Li, Hui
Li, Chunmei
Wei, Jia
Liu, Yunhua
Gong, Ming
Zhang, Ruyi
Geng, Jiawei
Wang, Hongyan
Yu, Zhijian
Wang, Zi
Liu, Xiang
HEPATOLOGY, 2023, 78 : S513 - S513
[36] Bone and Renal Safety Are Improved in Chronic HBV Patients 1 Year after Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF)
Seto, Wai Kay Walter
Buti, Maria
Izumi, Namiki
Lim, Young-Suk
Kao, Jia-Horng
Streinu-Cercel, Adrian
Nurmukhametova, Elena
Ma, Xiaoli
Tabak, Fehmi
Jablkowski, Maciej
Suri, Vithika
Flaherty, John F.
Lau, Audrey H.
Gaggar, Anuj
Mo, Shuyuan
Chowdhury, Abhijit
Fung, Scott K.
Chuang, Wan-Long
Gane, Edward J.
HEPATOLOGY, 2018, 68 : 240A - 241A
[37] BONE AND RENAL SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 8 YEARS IN CHRONIC HBV ( CHB) PATIENTS WITH UNDERLYING RISK FACTORS FOR USE OF TENOFOVIR DISOPROXIL FUMARATE ( TDF)
Buti, Maria
Gane, Edward J.
Agarwal, Kosh
Wong, Grace Lai-Hung C.
Lim, Young-Suk
Chen, Chi-Yi
Lim, Seng Gee
Yatsuhashi, Hiroshi
Fung, Scott K.
Abramov, Frida
Wang, Hongyuan
Yee, Leland J.
Flaherty, John F.
Pan, Calvin Q.
Marcellin, Patrick
HEPATOLOGY, 2023, 78 : S507 - S509
[38] TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS EMTRICITABINE PLUS TDF (FTC/TDF) FOR TREATMENT OF CHRONIC HEPATITIS B (CHB) IN PATIENTS WITH PERSISTENT VIRAL REPLICATION RECEIVING ADEFOVIR DIPIVOXIL: FINAL WEEK 168 RESULTS
Berg, Thomas
Marcellin, Patrick
Moeller, Bernd
Trinh, Huy N.
Chan, Sing
Suarez, Emilio
Snow-Lampart, Andrea
Peschell, Kenneth J.
Borroto-Esoda, Katyna
Hirsch, Kenneth R.
Frederick, David
HEPATOLOGY, 2010, 52 (04) : 387A - 388A
[39] SAFETY AND TOLERABILITY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBeAg NEGATIVE AND POSITIVE PATIENTS INFECTED WITH CHRONIC HEPATITIS B (CHB)
Marcellin, P.
Heathcote, E. J.
Jacobson, I.
Mathurin, P.
Gane, E.
Buggisch, P.
Husa, P.
Krastev, Z.
Sorbel, J.
Anderson, J.
Mondou, E.
Rousseau, F.
JOURNAL OF HEPATOLOGY, 2009, 50 : S336 - S337
[40] Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Chan, Henry Lik Yuen
Lim, Young-Suk
Seto, Wai Kay Walter
Agarwal, Kosh
Brunetto, Maurizia R.
Janssen, Harry L. A.
Caruntu, Florin
Stepanova, Tatjana
Tsang, Owen
Yatsuhashi, Hiroshi
Tak, Won Young
Chen, Chi-Yi
Celen, Mustafa
Suri, Vithika
Flaherty, John F.
Lin, Lanjia
Cathcart, Andrea
Gaggar, Anuj
Pan, Calvin Q.
Shalimar
Buti, Maria
HEPATOLOGY, 2018, 68 : 227A - 228A

← 1 2 3 4 5 →